The role of regulatory T cells in cutaneous disorders

  • Katie E. Birch
  • Milica Vukmanovic-Stejic
  • John R. Reed
  • Malcolm H.A. Rustin
  • Arne N. Akbarl
Part of the Progress in Inflammation Research book series (PIR)


Atopic Dermatitis Visceral Leishmaniasis Allergy Clin Immunol Purify Protein Derivative Atopic Dermatitis Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shevach EM (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2: 389–400PubMedGoogle Scholar
  2. 2.
    Baecher-Allan C, Hafler DA (2004) Suppressor T cells in human diseases. J Exp Med 200: 273–276PubMedGoogle Scholar
  3. 3.
    Ou LS, Goleva E, Hall C, Leung DY (2004) T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 113: 756–763PubMedGoogle Scholar
  4. 4.
    Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pita O, Girolomoni G (2003) Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 171: 5760–5768PubMedGoogle Scholar
  5. 5.
    Teraki Y, Shiohara T (2003) IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption. J Allergy Clin Immunol 112: 609–615PubMedGoogle Scholar
  6. 6.
    Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502–507PubMedGoogle Scholar
  7. 7.
    Adorini L (2002) Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2: 1017–1028PubMedGoogle Scholar
  8. 8.
    Elmets CA, Bergstresser PR, Tigelaar RE, Wood PJ, Streilein JW (1983) Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J Exp Med 158: 781–794PubMedGoogle Scholar
  9. 9.
    Steitz J, Bruck J, Lenz J, Knop J, Tuting T (2001) Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. Cancer Res 61: 8643–8646PubMedGoogle Scholar
  10. 10.
    Taams LS, Vukmanovic-Stejic M, Smith J, Dunne PJ, Fletcher JM, Plunkett FJ, Ebeling SB, Lombardi G, Rustin MH, Bijlsma JW et al (2002) Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol 32: 1621–1630PubMedGoogle Scholar
  11. 11.
    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151–1164PubMedGoogle Scholar
  12. 12.
    Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH (2001) Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193: 1285–1294PubMedGoogle Scholar
  13. 13.
    Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN (2001) Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 31: 1122–1131PubMedGoogle Scholar
  14. 14.
    Stephens LA, Mottet C, Mason D, Powrie F (2001) Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 31: 1247–1254PubMedGoogle Scholar
  15. 15.
    Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737–742PubMedGoogle Scholar
  16. 16.
    Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237–1240PubMedGoogle Scholar
  17. 17.
    Thornton AM, Shevach EM (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188: 287–296PubMedGoogle Scholar
  18. 18.
    Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190: 995–1004PubMedGoogle Scholar
  19. 19.
    Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, Strober W (2004) TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 172: 834–842PubMedGoogle Scholar
  20. 20.
    Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA (2003) IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33: 1205–1214PubMedGoogle Scholar
  21. 21.
    Colantonio L, Iellem A, Sinigaglia F, D’Ambrosio D (2002) Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309. Eur J Immunol 32: 3506–3514PubMedGoogle Scholar
  22. 22.
    Schaerli P, Ebert L, Willimann K, Blaser A, Roos RS, Loetscher P, Moser B (2004) A Skin-selective homing mechanism for human immune surveillance T cells. J Exp Med 199: 1265–1275PubMedGoogle Scholar
  23. 23.
    Pribila JT, Quale AC, Mueller KL, Shimizu Y (2004) Integrins and T cell-mediated immunity. Annu Rev Immunol 22: 157–180PubMedGoogle Scholar
  24. 24.
    Lehmann J, Huehn J, de la Rosa M, Maszyna F, Kretschmer U, Krenn V, Brunner M, Scheffold A, Hamann A (2002) Expression of the integrin alpha E beta 7 identifies unique subsets of CD25+ as well as CD25 regulatory T cells. Proc Natl Acad Sci USA 99: 13031–13036PubMedGoogle Scholar
  25. 25.
    Stassen M, Fondel S, Bopp T, Richter C, Muller C, Kubach J, Becker C, Knop J, Enk AH, Schmitt S et al (2004) Human CD25+ regulatory T cells: two subsets defined by the integrins alpha4beta7 or alpha4betal confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 34: 1303–1311PubMedGoogle Scholar
  26. 26.
    Patel DD (2001) Escape from tolerance in the human X-linked autoimmunity-allergic disregulation syndrome and the Scurfy mouse. J Clin Invest 107: 155–157PubMedGoogle Scholar
  27. 27.
    Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J, Carr VA, Robinson DS (2004) Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363: 608–615PubMedGoogle Scholar
  28. 28.
    Cottrez F, Hurst SD, Coffman RL, Groux H (2000) T regulatory cells 1 inhibit a Th2-specific response in vivo. JImmunol 165: 4848–4853Google Scholar
  29. 29.
    Curotto de Lafaille MA, Muriglan S, Sunshine MJ, Lei Y, Kutchukhidze N, Furtado GC, Wensky AK, Olivares-Villagomez D, Lafaille JJ (2001) Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes. J Exp Med 194: 1349–1359PubMedGoogle Scholar
  30. 30.
    Bellinghausen I, Klostermann B, Knop J, Saloga J (2003) Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol 111: 862–868PubMedGoogle Scholar
  31. 31.
    Furue M, Koga T, Yamashita N (1999) Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis. Br J Dermatol 140: 67–72PubMedGoogle Scholar
  32. 32.
    Wakita H, Sakamoto T, Tokura Y, Takigawa M (1994) E-selectin and vascular cell adhesion molecule-1 as critical adhesion molecules for infiltration of T lymphocytes and eosinophils in atopic dermatitis. J Cutan Pathol 21: 33–39PubMedGoogle Scholar
  33. 33.
    Cosmi L, Liotta F, Angeli R, Mazzinghi B, Santarlasci V, Manetti R, Lasagni L, Vanini V, Romagnani P, Maggi E et al (2004) Th2 cells are less susceptible than Thl cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood 103: 3117–3121PubMedGoogle Scholar
  34. 34.
    Baecher-Allan C, Viglietta V, Hafler DA (2002) Inhibition of human CD4(+) CD25(+high) regulatory T cell function. J Immunol 169: 6210–6217PubMedGoogle Scholar
  35. 35.
    Hori S, Carvalho TL, Demengeot J (2002) CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 32: 1282–1291PubMedGoogle Scholar
  36. 36.
    Stewart GR, Robertson BD, Young DB (2003) Tuberculosis: a problem with persistence. Nat Rev Microbiol 1: 97–105PubMedGoogle Scholar
  37. 37.
    Schubach A, Haddad F, Oliveira-Neto MP, Degrave W, Pirmez C, Grimaldi G Jr, Fernandes O (1998) Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis 178: 911–914PubMedGoogle Scholar
  38. 38.
    Xu D, Liu H, Komai-Koma M, Campbell C, McSharry C, Alexander J, Liew FY (2003) CD4+CD25+ regulatory T cells suppress differentiation and functions of Thl and Th2 cells, Leishmania major infection, and colitis in mice. J Immunol 170: 394–399PubMedGoogle Scholar
  39. 39.
    Delgado JC, Tsai EY, Thim S, Baena A, Boussiotis VA, Reynes JM, Sath S, Grosjean P, Yunis EJ, Goldfeld AE (2002) Antigen-specific and persistent tuberculin energy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc Natl Acad Sci USA 99: 7576–7581PubMedGoogle Scholar
  40. 40.
    Sousa AO, Salem JI, Lee FK, Vercosa MC, Cruaud P, Bloom BR, Lagrange PH, David HL (1997) An epidemic of tuberculosis with a high rate of tuberculin energy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci USA 94: 13227–13232PubMedGoogle Scholar
  41. 41.
    Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A, Rousset D, Reynes JM, Goldfeld AE (2000) IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 105: 1317–1325PubMedGoogle Scholar
  42. 42.
    Belkaid Y, Hoffmann KF, Mendez S, Kamhawi S, Udey MC, Wynn TA, Sacks DL (2001) The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 194: 1497–1506PubMedGoogle Scholar
  43. 43.
    Traidl C, Sebastiani S, Albanesi C, Merk HF, Puddu P, Girolomoni G, Cavani A (2000) Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes. J Immunol 165: 3058–3064PubMedGoogle Scholar
  44. 44.
    Wang B, Fujisawa H, Zhuang L, Freed I, Howell BG, Shahid S, Shivji GM, Mak TW, Sauder DN (2000) CD4+ Thl and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J Immunol 165: 6783–6790PubMedGoogle Scholar
  45. 45.
    Lecart S, Boulay V, Raison-Peyron N, Bousquet J, Meunier L, Yssel H, Pene J (2001) Phenotypic characterization of human CD4+ regulatory T cells obtained from cutaneous dinitrochlorobenzene-induced delayed type hypersensitivity reactions. J Invest Dermatol 117: 318–325PubMedGoogle Scholar
  46. 46.
    Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G (2000) Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Thl immune responses. J Invest Dermatol 114: 295–302PubMedGoogle Scholar
  47. 47.
    Friedmann PS, Moss C, Shuster S, Simpson JM (1983) Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects. Clin Exp Immunol 53: 709–715PubMedGoogle Scholar
  48. 48.
    Akbar AN, Taams LS, Salmon M, Vukmanovic-Stejic M (2003) The peripheral generation of CD4+ CD25+ regulatory T cells. Immunology 109: 319–325PubMedGoogle Scholar
  49. 49.
    Aiba S, Manome H, Yoshino Y, Tagami H (2000) in vitro treatment of human transforming growth factor-betal-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology 101: 68–75PubMedGoogle Scholar
  50. 50.
    Staquet MJ, Sportouch M, Jacquet C, Schmitt D, Guesnet J, Peguet-Navarro J (2004) Moderate skin sensitizers can induce phenotypic changes on in vitro generated dendritic cells. Toxicol In Vitro 18: 493–500PubMedGoogle Scholar
  51. 51.
    Hwang JM, Yamanouchi J, Santamaria P, Kubes P (2004) A critical temporal window for selectin-dependent CD4+ lymphocyte homing and initiation of late-phase inflammation in contact sensitivity. J Exp Med 199: 1223–1234PubMedGoogle Scholar
  52. 52.
    Sebastiani S, Allavena P, Albanesi C, Nasorri F, Bianchi G, Traidl C, Sozzani S, Girolomoni G, Cavani A (2001) Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol 166: 996–1002PubMedGoogle Scholar
  53. 53.
    Hoffmann P, Eder R, Kunz-Schughart LA, Andreesen R, Edinger M (2004) Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104: 895–903PubMedGoogle Scholar
  54. 54.
    Kira M, Kobayashi T, Yoshikawa K (2003) Vitamin D and the skin. J Dermatol 30: 429–437PubMedGoogle Scholar
  55. 55.
    Chen X, Murakami T, Oppenheim JJ, Howard OM (2004) Differential response of murine CD4+CD25+ and CD4+. Eur J Immunol 34: 859–869PubMedGoogle Scholar
  56. 56.
    Lebwohl M, Ali S (2001) Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol 45: 649–661PubMedGoogle Scholar
  57. 57.
    Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L (2001) Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 167: 1945–1953PubMedGoogle Scholar
  58. 58.
    Reitamo S, Wollenberg A, Schopf E, Perrot JL, Marks R, Ruzicka T, Christophers E, Kapp A, Lahfa M, Rubins A et al (2000) Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 136: 999–1006PubMedGoogle Scholar
  59. 59.
    Toews GB, Bergstresser PR, Streilein JW (1980) Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 124: 445–453PubMedGoogle Scholar
  60. 60.
    Schwarz A, Maeda A, Wild MK, Kernebeck K, Gross N, Aragane Y, Beissert S, Vestweber D, Schwarz T (2004) Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol 172: 1036–1043PubMedGoogle Scholar
  61. 61.
    Shreedhar VK, Pride MW, Sun Y, Kripke ML, Strickland FM (1998) Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J Immunol 161: 1327–1335PubMedGoogle Scholar
  62. 62.
    Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, Salomon BL, Cohen JL (2003) Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 112: 1688–1696PubMedGoogle Scholar
  63. 63.
    Trenado A, Fisson S, Braunberger E, Klatzmann D, Salomon BL, Cohen JL (2004) Ex vivo selection of recipient-type alloantigen-specific CD4(+)CD25(+) immunoregulatory T cells for the control of graft-versus-host disease after allogeneic hematopoietic stem-cell transplantation. Transplantation 77: S32–S34PubMedGoogle Scholar
  64. 64.
    Graca L, Cobbold SP, Waldmann H (2002) Identification of regulatory T cells in tolerated allografts. J Exp Med 195: 1641–1646PubMedGoogle Scholar
  65. 65.
    Kingsley CI, Karim M, Bushell AR, Wood KJ (2002) CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4-and IL-10-dependent immunoregulation of alloresponses. J Immunol 168: 1080–1086PubMedGoogle Scholar
  66. 66.
    Morris ES, MacDonald KP, Rowe V, Johnson DH, Banovic T, Clouston AD, Hill GR (2004) Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood 103: 3573–3581PubMedGoogle Scholar
  67. 67.
    Waldmann H, Graca L, Cobbold S, Adams E, Tone M, Tone Y (2004) Regulatory T cells and organ transplantation. Semin Immunol 16: 119–126PubMedGoogle Scholar
  68. 68.
    Krueger JG, Walters IB, Miyazawa M, Gilleaudeau P, Hakimi J, Light S, Sherr A, Gottlieb AB (2000) Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis. J Am Acad Dermatol 43: 448–458PubMedGoogle Scholar
  69. 69.
    Mrowietz U, Zhu K, Christophers E (2000) Treatment of severe psoriasis with antiCD25 monoclonal antibodies. Arch Dermatol 136: 675–676PubMedGoogle Scholar
  70. 70.
    Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B (2003) Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 9: 606–612PubMedGoogle Scholar
  71. 71.
    Lens MB, Dawes M (2004) Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 150: 179–185PubMedGoogle Scholar
  72. 72.
    Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59: 3128–3133PubMedGoogle Scholar
  73. 73.
    Steitz J, Bruck J, Lenz J, Knop J, Tuting T (2001) Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. Cancer Res 61: 8643–8646PubMedGoogle Scholar
  74. 74.
    Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP, Toes RE, Offringa R, Melief CJ (2001) Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 194: 823–832PubMedGoogle Scholar
  75. 75.
    O’Garra A, Vieira P (2004) Regulatory T cells and mechanisms of immune system control. Nat Med 10: 801–805PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2005

Authors and Affiliations

  • Katie E. Birch
    • 1
    • 2
  • Milica Vukmanovic-Stejic
    • 1
  • John R. Reed
    • 1
  • Malcolm H.A. Rustin
    • 2
  • Arne N. Akbarl
    • 1
  1. 1.Department of Immunology and Molecular Pathology, Division of Infection and ImmunityUniversity College LondonLondonUK
  2. 2.Department of DermatologyRoyal Free HospitalLondonUK

Personalised recommendations